Literature DB >> 21537427

Renal function in diabetic nephropathy.

Pradeep Kumar Dabla1.   

Abstract

Diabetic nephropathy is the kidney disease that occurs as a result of diabetes. Cardiovascular and renal complications share common risk factors such as blood pressure, blood lipids, and glycemic control. Thus, chronic kidney disease may predict cardiovascular disease in the general population. The impact of diabetes on renal impairment changes with increasing age. Serum markers of glomerular filtration rate and microalbuminuria identify renal impairment in different segments of the diabetic population, indicating that serum markers as well as microalbuminuria tests should be used in screening for nephropathy in diabetic older people. The American Diabetes Association and the National Institutes of Health recommend Estimated glomerular filtration rate (eGFR) calculated from serum creatinine at least once a year in all people with diabetes for detection of kidney dysfunction. eGFR remains an independent and significant predictor after adjustment for conventional risk factors including age, sex, duration of diabetes, smoking, obesity, blood pressure, and glycemic and lipid control, as well as presence of diabetic retinopathy. Cystatin-C (Cys C) may in future be the preferred marker of diabetic nephropathy due differences in measurements of serum creatinine by various methods. The appropriate reference limit for Cys C in geriatric clinical practice must be defined by further research. Various studies have shown the importance of measurement of albuminuria, eGFR, serum creatinine and hemoglobin level to further enhance the prediction of end stage renal disease.

Entities:  

Keywords:  Chronic kidney disease; Cockcroft-Gault formula; Cystatin-C; End stage renal disease; Estimated glomerular filtration rate; Glomerular filtration rate; Microalbumin; Modification of diet; Renal disease

Year:  2010        PMID: 21537427      PMCID: PMC3083882          DOI: 10.4239/wjd.v1.i2.48

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  75 in total

1.  Validity of rapid estimation of glomerular filtration rate in type 2 diabetic patients with normal renal function.

Authors:  S Nielsen; M Rehling; A Schmitz; C E Mogensen
Journal:  Nephrol Dial Transplant       Date:  1999-03       Impact factor: 5.992

2.  Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes.

Authors:  E Korpinen; A M Teppo; L Hukkanen; H K Akerblom; C Grönhagen-Riska; O Vaarala
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

3.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

Review 4.  Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study.

Authors:  Coen D A Stehouwer; Ronald M A Henry; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Lex M Bouter
Journal:  Kidney Int Suppl       Date:  2004-11       Impact factor: 10.545

5.  Influence of body weight on the performance of glomerular filtration rate estimators in subjects with type 2 diabetes.

Authors:  Richard A Chudleigh; Gareth Dunseath; Rajesh Peter; John N Harvey; Richard L Ollerton; Steve Luzio; David R Owens
Journal:  Diabetes Care       Date:  2007-10-12       Impact factor: 19.112

6.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Saverio Parlongo; Lorenzo S Malatino; Graziella Bonanno; Giuseppe Seminara; Francesco Rapisarda; Pasquale Fatuzzo; Michele Buemi; Giacomo Nicocia; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

7.  [Urinary proteins in patients with diabetes mellitus].

Authors:  W Hofmann; W G Guder
Journal:  Klin Wochenschr       Date:  1989

8.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.

Authors:  Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

Review 9.  CCN proteins: multifunctional signalling regulators.

Authors:  Bernard Perbal
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

10.  The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.

Authors:  William F Keane; Barry M Brenner; Dick de Zeeuw; Jean-Pierre Grunfeld; Janet McGill; William E Mitch; Artur B Ribeiro; Shahnaz Shahinfar; Roger L Simpson; Steven M Snapinn; Robert Toto
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

View more
  49 in total

1.  Does glimepiride alter the pharmacokinetics of sildenafil citrate in diabetic nephropathy animals: investigating mechanism of interaction by molecular modeling studies.

Authors:  Alok Shiomurti Tripathi; Ajay Kumar Timiri; Papiya Mitra Mazumder; Anil Chandewar
Journal:  J Mol Model       Date:  2015-10-01       Impact factor: 1.810

2.  Ultrasonographic Renal Dimensions Amongst Adult Nigerian Diabetics: Correlation with Clinical, Anthropometric and Metabolic Risk Factors.

Authors:  S S Assenyi; A J Adekanmi
Journal:  Afr J Biomed Res       Date:  2020-07

3.  Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy.

Authors:  Sahabuddin Ahmed; Nitin Mundhe; Manash Borgohain; Liakat Chowdhury; Mohit Kwatra; Nityanand Bolshette; Anwaruddin Ahmed; Mangala Lahkar
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

4.  Kidney Injury Molecule Levels in Type 2 Diabetes Mellitus.

Authors:  Ozgur Aslan; Metin Demir; Mehmet Koseoglu
Journal:  J Clin Lab Anal       Date:  2016-05-02       Impact factor: 2.352

Review 5.  Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications.

Authors:  Ana Gabriela Murillo; Maria Luz Fernandez
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

6.  In vivo studies demonstrate that endothelin-1 traps are a potential therapy for type I diabetes.

Authors:  Arjun Jain; Vidhi Mehrotra; Ira Jha; Ashok Jain
Journal:  J Diabetes Metab Disord       Date:  2019-04-08

7.  Therapeutic Potentials of Colocasia affinis Leaf Extract for the Alleviation of Streptozotocin-Induced Diabetes and Diabetic Complications: In vivo and in silico-Based Studies.

Authors:  Manik Chandra Shill; Asim Kumar Bepari; Mahi Khan; Zarin Tasneem; Tania Ahmed; Md Asif Hasan; Md Jahir Alam; Murad Hossain; Md Ashrafur Rahman; Shazid Md Sharker; Masum Shahriar; Ghazi Muhammad Sayedur Rahman; Hasan Mahmud Reza
Journal:  J Inflamm Res       Date:  2021-02-19

8.  Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib.

Authors:  Nehal Mohsen Elsherbiny; Mohamed El-Sherbiny; Eman Said
Journal:  J Physiol Biochem       Date:  2015-08-21       Impact factor: 4.158

9.  Risk factors for subclinical renal damage and its progression: Hanzhong Adolescent Hypertension Study.

Authors:  Yang Wang; Ming-Fei Du; Wei-Hua Gao; Bo-Wen Fu; Qiong Ma; Yu Yan; Yue Yuan; Chao Chu; Chen Chen; Yue-Yuan Liao; Ke Gao; Ke-Ke Wang; Min Li; Yue Sun; Jia-Wen Hu; Xin Chen; Qiong Ma; Dan Wang; Xiao-Yu Zhang; Chun-Hua Li; Hao-Wei Zhou; Wan-Hong Lu; Zu-Yi Yuan; John Chang; Jian-Jun Mu
Journal:  Eur J Clin Nutr       Date:  2020-09-29       Impact factor: 4.016

10.  Advanced glycation end products and their receptors in serum of patients with type 2 diabetes.

Authors:  Diana Indyk; Agnieszka Bronowicka-Szydełko; Andrzej Gamian; Aleksandra Kuzan
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.